Short Interest in NuCana plc Decreases By 63.2

NCNA Stock  USD 1.25  0.01  0.79%   
About 62% of NuCana PLC's investor base is looking to short. The analysis of the overall investor sentiment regarding NuCana PLC suggests that many traders are alarmed. The current market sentiment, together with NuCana PLC's historical and current headlines, can help investors time the market. In addition, many technical investors use NuCana PLC stock news signals to limit their universe of possible portfolio assets.
  
NuCana plc saw a significant drop in short interest in January. As of January 31st, there was short interest totalling 72,900 shares, a drop of 63.2 percent from the January 15th total of 198,200 shares. Currently, 0.2 percent of the companys stock are short sold. Based on an average daily trading volume, of

Read at thelincolnianonline.com
news
  

NuCana PLC Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards NuCana PLC can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

NuCana PLC Fundamental Analysis

We analyze NuCana PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NuCana PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NuCana PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Shares Shorted

Number Of Shares Shorted Comparative Analysis

NuCana PLC is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

NuCana PLC Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NuCana PLC stock to make a market-neutral strategy. Peer analysis of NuCana PLC could also be used in its relative valuation, which is a method of valuing NuCana PLC by comparing valuation metrics with similar companies.

Peers

NuCana PLC Related Equities

CTMXCytomX Therapeutics   12.84   
0%
100.0%
CRVSCorvus Pharmaceuticals   0.36   
0%
2.0%
DAWNDay One   1.81   
14.0%
0%
RANIRani Therapeutics   2.00   
15.0%
0%
MREOMereo BioPharma   2.20   
17.0%
0%
ZVSAZyVersa Therapeutics   2.91   
22.0%
0%
ABOSAcumen Pharmaceuticals   2.98   
23.0%
0%
TNYATenaya Therapeutics   3.35   
26.0%
0%
APLTApplied Therapeutics   3.43   
26.0%
0%
ZURAZura Bio   3.57   
27.0%
0%
CDTXCidara Therapeutics   5.60   
43.0%
0%
INZYInozyme Pharma   6.09   
47.0%
0%
SLNSilence Therapeutics   6.23   
48.0%
0%
ALXOAlx Oncology   6.63   
51.0%
0%
VINCVincerx Pharma   10.34   
80.0%
0%

Complementary Tools for NuCana Stock analysis

When running NuCana PLC's price analysis, check to measure NuCana PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NuCana PLC is operating at the current time. Most of NuCana PLC's value examination focuses on studying past and present price action to predict the probability of NuCana PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NuCana PLC's price. Additionally, you may evaluate how the addition of NuCana PLC to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk